
Abu Dhabi's M42 partners with UK firm to develop AI-driven therapeutics for age-related diseases
Abu Dhabi's M42 has announced a partnership and investment in UK-based longevity biotech leader Juvenescence. The new alliance is aimed at discovering and developing AI-enabled therapeutics to advance the treatment of life-threatening and age-related …